GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BriaCell Therapeutics Corp (TSX:BCT) » Definitions » Pretax Margin %

BriaCell Therapeutics (TSX:BCT) Pretax Margin % : % (As of Jan. 2024)


View and export this data going back to 2006. Start your Free Trial

What is BriaCell Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BriaCell Therapeutics's Pre-Tax Income for the three months ended in Jan. 2024 was C$-15.21 Mil. BriaCell Therapeutics's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil. Therefore, BriaCell Therapeutics's pretax margin for the quarter that ended in Jan. 2024 was %.

The historical rank and industry rank for BriaCell Therapeutics's Pretax Margin % or its related term are showing as below:


TSX:BCT's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -155.67
* Ranked among companies with meaningful Pretax Margin % only.

BriaCell Therapeutics Pretax Margin % Historical Data

The historical data trend for BriaCell Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BriaCell Therapeutics Pretax Margin % Chart

BriaCell Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BriaCell Therapeutics Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BriaCell Therapeutics's Pretax Margin %

For the Biotechnology subindustry, BriaCell Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BriaCell Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Pretax Margin % falls into.



BriaCell Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

BriaCell Therapeutics's Pretax Margin for the fiscal year that ended in Jul. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=-26.821/0
= %

BriaCell Therapeutics's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-15.214/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BriaCell Therapeutics  (TSX:BCT) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


BriaCell Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BriaCell Therapeutics (TSX:BCT) Business Description

Traded in Other Exchanges
Address
235 - 15th Street, Suite 300, West Vancouver, 3rd Floor, Bellevue Centre, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Executives
Jamieson Bondarenko Director

BriaCell Therapeutics (TSX:BCT) Headlines

No Headlines